Artificial Intelligence for Clinical Management of Male Infertility, a Scoping Review.

IF 2.5 2区医学 Q2 UROLOGY & NEPHROLOGY

Current Urology Reports Pub Date : 2024-11-09 DOI:10.1007/s11934-024-01239-z

Noopur Naik, Bradley Roth, Scott D Lundy

{"title":"Artificial Intelligence for Clinical Management of Male Infertility, a Scoping Review.","authors":"Noopur Naik, Bradley Roth, Scott D Lundy","doi":"10.1007/s11934-024-01239-z","DOIUrl":null,"url":null,"abstract":"Purpose of review: Infertility impacts one in six couples worldwide, with male infertility contributing to approximately half of these cases. However, the causes of infertility remain incompletely understood, and current methods of clinical management are cost-restrictive, time-intensive, and have limited success. Artificial intelligence (AI) may help address some of these challenges. In this review, we synthesize recent literature in AI with implications for the clinical management of male infertility.Recent findings: Artificial intelligence may offer opportunities for proactive, cost-effective, and efficient management of male infertility, specifically in the areas of hypogonadism, semen analysis, and interventions such as assisted reproductive technology. Patients may benefit from the integration of AI into a male infertility specialist's clinical workflow. The ability of AI to integrate large volumes of data into predictive models could help clinicians guide conversations with patients on the value of various treatment options in infertility, but caution must be taken to ensure the quality of care being delivered remains high.","PeriodicalId":11112,"journal":{"name":"Current Urology Reports","volume":"26 1","pages":"17"},"PeriodicalIF":2.5000,"publicationDate":"2024-11-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11550229/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current Urology Reports","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s11934-024-01239-z","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

Purpose of review: Infertility impacts one in six couples worldwide, with male infertility contributing to approximately half of these cases. However, the causes of infertility remain incompletely understood, and current methods of clinical management are cost-restrictive, time-intensive, and have limited success. Artificial intelligence (AI) may help address some of these challenges. In this review, we synthesize recent literature in AI with implications for the clinical management of male infertility.

Recent findings: Artificial intelligence may offer opportunities for proactive, cost-effective, and efficient management of male infertility, specifically in the areas of hypogonadism, semen analysis, and interventions such as assisted reproductive technology. Patients may benefit from the integration of AI into a male infertility specialist's clinical workflow. The ability of AI to integrate large volumes of data into predictive models could help clinicians guide conversations with patients on the value of various treatment options in infertility, but caution must be taken to ensure the quality of care being delivered remains high.

查看原文本刊更多论文

人工智能在男性不育症临床治疗中的应用，范围综述。

回顾的目的：全世界每六对夫妇中就有一对患有不孕症，其中约一半是男性不育症。然而，人们对不孕不育症的病因仍然知之甚少，目前的临床治疗方法成本高、耗时长，而且效果有限。人工智能（AI）可能有助于应对其中的一些挑战。在这篇综述中，我们总结了人工智能领域的最新文献，这些文献对男性不育症的临床治疗具有重要意义：人工智能可为男性不育症提供主动、经济、高效的管理机会，特别是在性腺功能减退症、精液分析和辅助生殖技术等干预领域。将人工智能整合到男性不育专科医生的临床工作流程中，患者可能会从中受益。人工智能将大量数据整合到预测模型中的能力可以帮助临床医生指导与患者就不孕症各种治疗方案的价值进行对话，但必须谨慎从事，以确保提供高质量的医疗服务。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Current Urology Reports UROLOGY & NEPHROLOGY-

CiteScore

4.60

自引率

3.80%

发文量

期刊介绍： This journal intends to review the most important, recently published findings in the field of urology. By providing clear, insightful, balanced contributions by international experts, the journal elucidates current and emerging approaches to the care and prevention of urologic diseases and conditions. We accomplish this aim by appointing international authorities to serve as Section Editors in key subject areas, such as benign prostatic hyperplasia, erectile dysfunction, female urology, and kidney disease. Section Editors, in turn, select topics for which leading experts contribute comprehensive review articles that emphasize new developments and recently published papers of major importance, highlighted by annotated reference lists. An international Editorial Board reviews the annual table of contents, suggests articles of special interest to their country/region, and ensures that topics are current and include emerging research. Commentaries from well-known figures in the field are also provided.